Tumor mutation burden in blood predicts benefit from neoadjuvant chemo/radiotherapy in locally advanced rectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor mutation burden in blood predicts benefit from neoadjuvant chemo/radiotherapy in locally advanced rectal cancer

Published:2021-01 Issue:1 Volume:113 Page:957-966
ISSN:0888-7543
Container-title:Genomics
language:en
Short-container-title:Genomics

Author:

Ji Dengbo,Zhang Dakui,Zhan Tiancheng,Jia Jinying,Han Wenbo,Li Zhaowei,Li Ming,Song Can,Wang Jianfei,Gu Jin

Funder

National Natural Science Foundation of China

Beijing Municipal Natural Science Foundation

Publisher

Elsevier BV

Subject

Genetics

Reference41 articles.

1. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer;Braendengen;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2008

2. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials;Lancet,2001

3. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial;van Gijn;Lancet Oncol.,2011

4. Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge;Engelen;Eur. J. Cancer,2013

5. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data;Breugom;Lancet Oncol.,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ctDNA as a predictor of outcome after curative resection for locally advanced rectal cancer: systematic review and meta‐analysis;Colorectal Disease;2024-05-27

2. The frequency of ctDNA with KRAS, NRAS, and BRAF mutations in colorectal cancer is associated with the mutation site;2023-11-29

3. Association of ctDNA detection and recurrence assessment in patients with neoadjuvant treatment;Cancer Medicine;2023-09-25

4. The potential role of minimal/molecular residual disease in colorectal cancer: curative surgery, radiotherapy and beyond;Journal of the National Cancer Center;2023-09

5. Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study;Pharmaceuticals;2023-03-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3